8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
IQVIA filed an 8‑K (Item 9.01) furnishing a press release dated Feb 5, 2026 (Exhibit 99.1) and the iXBRL…
Filed with the SEC on · Summarized by InvestorsBot
IQVIA filed an 8‑K (Item 9.01) furnishing a press release dated Feb 5, 2026 (Exhibit 99.1) and the iXBRL cover page (Exhibit 104). Filing signed by CFO Ronald E. Bruehlman. Read the press release for details. $IQV 🧾 #8K #Healthcare
Item 9.01 lists only exhibits—no new financial statements or other Form 8‑K items disclosed. Investors should review the Feb 5 press release for any material developments. $IQV 🔍 #Investing #ClinicalResearch